HAEMONETICS CORP/MASS (HAE)

US4050241003 - Common Stock

85.43  +0.51 (+0.6%)

After market: 85.43 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

HAEMONETICS CORP/MASS

NYSE:HAE (11/21/2024, 8:04:00 PM)

After market: 85.43 0 (0%)

85.43

+0.51 (+0.6%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-3.29%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap4.29B
Shares
PE20.94
Fwd PE15.88
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

HAE Daily chart

Company Profile

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. The company is headquartered in Boston, Massachusetts and currently employs 3,657 full-time employees. The firm is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment includes blood collection and processing devices and disposables for red cells, platelets and whole blood. The Company’s Hospital segment consists of Interventional Technologies, which includes vascular closure devices and sensor-guided technologies, and Blood Management Technologies, which includes devices and methodologies for measuring coagulation characteristics of blood, and blood transfusion management software, among others.

Company Info

HAEMONETICS CORP/MASS

125 Summer Street

Boston MASSACHUSETTS 02110

P: 17818487100

CEO: Christopher A. Simon

Employees: 3657

Website: https://www.haemonetics.com

HAE News

ChartMill News Image17 hours ago - ChartmillFor those who appreciate growth without the sticker shock, NYSE:HAE is worth considering.

In the world of growth stocks, NYSE:HAE shines as a value proposition.

News Image15 days ago - Market News VideoHaemonetics (HAE) Shares Cross Above 200 DMA
News Image15 days ago - Haemonetics CorporationHaemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website

/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2025, which ended September 28, 2024,...

News Imagea month ago - Market News VideoHaemonetics Larger Than S&P 500 Component Deckers Outdoor
News Imagea month ago - Market News VideoNotable Tuesday Option Activity: APLS, HAE, LULU
News Image2 months ago - Haemonetics CorporationHaemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024

/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2025 financial results at 6:00 am...

HAE Twits

Here you can normally see the latest stock twits on HAE, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example